1. Home
  2. MXL vs NEO Comparison

MXL vs NEO Comparison

Compare MXL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXL
  • NEO
  • Stock Information
  • Founded
  • MXL 2003
  • NEO 2001
  • Country
  • MXL United States
  • NEO United States
  • Employees
  • MXL N/A
  • NEO N/A
  • Industry
  • MXL Semiconductors
  • NEO Precision Instruments
  • Sector
  • MXL Technology
  • NEO Health Care
  • Exchange
  • MXL Nasdaq
  • NEO Nasdaq
  • Market Cap
  • MXL 1.2B
  • NEO 1.2B
  • IPO Year
  • MXL 2010
  • NEO 1999
  • Fundamental
  • Price
  • MXL $16.95
  • NEO $10.06
  • Analyst Decision
  • MXL Buy
  • NEO Buy
  • Analyst Count
  • MXL 8
  • NEO 10
  • Target Price
  • MXL $20.93
  • NEO $12.56
  • AVG Volume (30 Days)
  • MXL 1.1M
  • NEO 4.3M
  • Earning Date
  • MXL 10-23-2025
  • NEO 10-28-2025
  • Dividend Yield
  • MXL N/A
  • NEO N/A
  • EPS Growth
  • MXL N/A
  • NEO N/A
  • EPS
  • MXL N/A
  • NEO N/A
  • Revenue
  • MXL $378,015,000.00
  • NEO $689,189,000.00
  • Revenue This Year
  • MXL $28.85
  • NEO $10.40
  • Revenue Next Year
  • MXL $17.69
  • NEO $10.11
  • P/E Ratio
  • MXL N/A
  • NEO N/A
  • Revenue Growth
  • MXL N/A
  • NEO 9.70
  • 52 Week Low
  • MXL $8.35
  • NEO $4.72
  • 52 Week High
  • MXL $25.73
  • NEO $19.12
  • Technical
  • Relative Strength Index (RSI)
  • MXL 55.09
  • NEO 72.59
  • Support Level
  • MXL $14.36
  • NEO $8.68
  • Resistance Level
  • MXL $17.80
  • NEO $10.40
  • Average True Range (ATR)
  • MXL 0.98
  • NEO 0.45
  • MACD
  • MXL 0.12
  • NEO 0.10
  • Stochastic Oscillator
  • MXL 75.07
  • NEO 89.26

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: